Search Results

INOVIO Added to Russell 2000® Index Effective July 1, 2024

INOVIO announced its inclusion in the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes.

July 1, 2024

·

3 min read

Pharm Country

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

INOVIO today announced that INOVIO’s President and CEO, Dr. Jacqueline Shea , and Chief Medical Officer, Dr. Michael Sumner will participate in a virtual fireside chat hosted by Sudan Loganathan, Ph.D., Managing Director and equity research analyst at Stephens, Inc.

June 4, 2024

·

1 min read

Pharm Country

INOVIO to Participate in Upcoming Investor Conferences in May

INOVIO today announced that management will participate in the following investor conferences during the month of May.

April 29, 2024

·

1 min read

Pharm Country

INOVIO Reports Inducement Grants Under Inducement Plan - May 31, 2024

INOVIO announced that it has made an equity grant to a newly hired employee under its 2022 Inducement Plan.

May 31, 2024

·

1 min read

Pharm Country

INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024

INOVIO today announced that first quarter 2024 financial results will be released after the market close on May 13, 2024.

April 29, 2024

·

1 min read

Deals

INOVIO Reports Inducement Grants Under Inducement Plan - May 1, 2024

INOVIO today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan (the “Inducement Plan”).

May 1, 2024

·

1 min read

Business

INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced its financial results for the first quarter of 2024 and provided an update on recent company developments.

May 13, 2024

·

15 min read

Pharm Country

INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine

INOVIO announced that Dr. Jacqueline Shea, President and CEO will participate in The Novel Therapeutics Forum hosted by Citizens JMP at Penn Medicine at 10:00 am ET on April 2, 2024.

March 26, 2024

·

1 min read

Deals

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO today announced that it has made an equity grant to a newly hired employee under its 2022 Inducement Plan (the “Inducement Plan”).

February 2, 2024

·

1 min read

Pharm Country

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024

INOVIO today announced that fourth quarter and year-end 2023 financial results will be released after the market close on March 6, 2024.

February 21, 2024

·

1 min read